1 | A (migalastat) | 1件: Migalastat Migalastat | 1件: Migalastat
Migalastat
💬
| - | - | 1件: 19 19 💬
|
2 | A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine | 3件: Clarithromycin Clarithromycin, Clofazimine, Rifabutin | 3件: Clarithromycin
Clarithromycin
,
Clofazimine
,
Rifabutin
💬
| - | - | 1件: 96 96 💬
|
3 | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | - | - | - | - | 1件: 60 60 💬
|
4 | A multistrain probiotic product (DSF) | - | - | - | - | 1件: 97 97 💬
|
5 | A Natural Remedy for Rheumatoid Arthritis vs. Common Drugs | - | - | - | - | 1件: 46 46 💬
|
6 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as | - | - | - | - | 1件: 254 254 💬
|
7 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R) | - | - | - | - | 1件: 51 51 💬
|
8 | A single blood sample for HLA typing | - | - | - | - | 3件: 35 35, 38, 162 💬
|
9 | A-1293543.74 | - | - | - | - | 1件: 96 96 💬
|
10 | A-623 | - | - | - | - | 1件: 49 49 💬
|
11 | A-623 or AMG 623 | - | - | - | - | 1件: 66 66 💬
|
12 | A-dopamine | 1件: Dopamine Dopamine | 1件: Dopamine
Dopamine
💬
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
13 | A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP) | - | - | - | - | 1件: 299 299 💬
|
14 | A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (NEOGAA) | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬
| 1件: GAA GAA 💬
| 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
15 | A01AC02 | - | - | - | - | 1件: 28 28 💬
|
16 | A042917017 | - | - | - | - | 1件: 21 21 💬
|
17 | A04AD10 | - | - | - | - | 1件: 298 298 💬
|
18 | A07DA03 | - | - | - | - | 1件: 97 97 💬
|
19 | A07EA06 | - | - | - | - | 1件: 66 66 💬
|
20 | A10BK03 | - | - | - | - | 1件: 65 65 💬
|
21 | A11HA02 | - | - | - | - | 1件: 93 93 💬
|
22 | A16AB04 | - | - | - | - | 1件: 19 19 💬
|
23 | A16AX06 | - | - | - | - | 1件: 19 19 💬
|
24 | A16AX07 | - | - | - | - | 1件: 240 240 💬
|
25 | A3907 | - | - | - | - | 1件: 94 94 💬
|
26 | A4250 | - | - | - | - | 4件: 93 93, 296, 297, 338 💬
|
27 | A4250 (1200 µg) | - | - | - | - | 1件: 338 338 💬
|
28 | A4250 (200 µg) | - | - | - | - | 1件: 338 338 💬
|
29 | A4250 (400 µg) | - | - | - | - | 1件: 338 338 💬
|
30 | A4250 (600 µg) | - | - | - | - | 1件: 338 338 💬
|
31 | A4250 (odevixibat) | 1件: Odevixibat Odevixibat | 1件: Odevixibat
Odevixibat
💬
| 1件: SLC10A2 SLC10A2 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 338 338 💬
|
32 | A4250-015 | - | - | - | - | 1件: 297 297 💬
|
33 | A4I Antagonist | - | - | - | - | 1件: 13 13 💬
|
34 | A: 1 dosis | - | - | - | - | 1件: 97 97 💬
|
35 | A: PTH (1-84) | - | - | - | - | 1件: 235 235 💬
|
36 | AAC Hexal | - | - | - | - | 1件: 299 299 💬
|
37 | Aadipose-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 6 6 💬
|
38 | AAV BBP-631 | - | - | - | - | 1件: 81 81 💬
|
39 | AAV directed hLDLR gene therapy | - | - | - | - | 1件: 79 79 💬
|
40 | AAV-GAD Dose 1 | - | - | - | - | 1件: 6 6 💬
|
41 | AAV-GAD Dose 2 | - | - | - | - | 1件: 6 6 💬
|
42 | AAV-hAADC-2 | - | - | - | - | 1件: 6 6 💬
|
43 | AAV-RPGR | - | - | - | - | 1件: 90 90 💬
|
44 | AAV1-gamma-sarcoglycan vector injection | - | - | - | - | 1件: 113 113 💬
|
45 | AAV2-GDNF | - | - | - | - | 1件: 6 6 💬
|
46 | AAV2-GDNF gene therapy | - | - | - | - | 1件: 17 17 💬
|
47 | AAV2-REP1 | - | - | - | - | 1件: 90 90 💬
|
48 | AAV2/5-hPDE6B | - | - | - | - | 1件: 90 90 💬
|
49 | AAV2/5-hRKp.RPGR | - | - | - | - | 1件: 90 90 💬
|
50 | AAV2/5-RPGR | - | - | - | - | 1件: 90 90 💬
|
51 | AAV2/8.TBG.hARSB | - | - | - | - | 1件: 19 19 💬
|
52 | AAV2CUhCLN2 (3x10^12 particle units) | - | - | - | - | 1件: 19 19 💬
|
53 | AAV5-HRKP.RPGR | - | - | - | - | 1件: 90 90 💬
|
54 | AAV5-RPGR | - | - | - | - | 1件: 90 90 💬
|
55 | AAV5-RPGR 2e11 | - | - | - | - | 1件: 90 90 💬
|
56 | AAV5-RPGR 4e11 | - | - | - | - | 1件: 90 90 💬
|
57 | AAV8-RPGR | - | - | - | - | 1件: 90 90 💬
|
58 | AAV8.TBG.hLDLR | - | - | - | - | 1件: 79 79 💬
|
59 | AAV9 BBP-812 | 1件: BBP-812 BBP-812 | - | - | - | 1件: 307 307 💬
|
60 | AAV9-CAG-coh-SGSH | - | - | - | - | 1件: 19 19 💬
|
61 | AAV9-GLB1 | - | - | - | - | 1件: 19 19 💬
|
62 | AAVLK03hOTC | - | - | - | - | 1件: 251 251 💬
|
63 | AAVrh.10-hMPSIIIA | - | - | - | - | 1件: 19 19 💬
|
64 | AAVrh.10cuARSA | - | - | - | - | 1件: 19 19 💬
|
65 | AAVrh.10CUCLN2 | - | - | - | - | 1件: 19 19 💬
|
66 | AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies | - | - | - | - | 1件: 19 19 💬
|
67 | AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies | - | - | - | - | 1件: 19 19 💬
|
68 | AAVrh10.CAG.hCYP46A1 | - | - | - | - | 1件: 8 8 💬
|
69 | AB (antibiotics) | - | - | - | - | 1件: 97 97 💬
|
70 | AB 1003 | - | - | - | - | 1件: 2 2 💬
|
71 | AB-1001 Gene Therapy | - | - | - | - | 1件: 8 8 💬
|
72 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
73 | ABA, open-label (OL) | - | - | - | - | 1件: 46 46 💬
|
74 | Abacavir | 1件: Abacavir Abacavir | 1件: Abacavir
Abacavir
💬
| - | - | 4件: 2 2, 135, 265, 325 💬
|
75 | Abacavir 300mg twice daily | 1件: Abacavir Abacavir | 1件: Abacavir
Abacavir
💬
| - | - | 1件: 265 265 💬
|
76 | Abacavir sulfate | 2件: Abacavir Abacavir, Sulfate ion | 1件: Abacavir
Abacavir
💬
| - | - | 1件: 265 265 💬
|
77 | Abacavir sulfate, Lamivudine and Zidovudine | 4件: Abacavir Abacavir, Lamivudine, Sulfate ion, Zidovudine | 3件: Lamivudine
Lamivudine
,
Zidovudine
,
Abacavir
💬
| - | - | 1件: 265 265 💬
|
78 | Abalimumab | - | - | - | - | 1件: 97 97 💬
|
79 | Abalimumab bio-originatore | - | - | - | - | 1件: 107 107 💬
|
80 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
81 | Abatacept (ABA) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 97 97 💬
|
82 | Abatacept (ABA) + Methotrexate (MTX), double-blind (DB) | 2件: Abatacept Abatacept, Methotrexate | 2件: Methotrexate
Methotrexate
,
Abatacept
💬
| 4件: CD80 CD80, CD86, DHFR, DHFR2 💬
| 18件: Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
83 | Abatacept (BMS-188667) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
84 | Abatacept (CTLA4-Ig) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 44 44 💬
|
85 | Abatacept (IV) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
86 | Abatacept (M3-M12) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
87 | Abatacept (SC) | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
88 | Abatacept + csDMARD | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
89 | Abatacept + Methotrexate | 2件: Abatacept Abatacept, Methotrexate | 2件: Methotrexate
Methotrexate
,
Abatacept
💬
| 4件: CD80 CD80, CD86, DHFR, DHFR2 💬
| 18件: Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
90 | Abatacept + Vaccines | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
91 | Abatacept Active Treatment | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 50 50 💬
|
92 | Abatacept also known as Orencia also known as CTLA4-Ig | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 49 49 💬
|
93 | Abatacept Delayed-Onset Treatment | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 50 50 💬
|
94 | Abatacept Injection | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 2件: 11 11, 46 💬
|
95 | Abatacept Placebo | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 2件: 46 46, 53 💬
|
96 | Abatacept Prefilled Syringe | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
97 | Abatacept SC | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 53 53 💬
|
98 | Abatacept, rituximab or tocilizumab | 3件: Abatacept Abatacept, Rituximab, Tocilizumab | 3件: Tocilizumab
Tocilizumab
,
Rituximab
,
Abatacept
💬
| 4件: CD80 CD80, CD86, IL6R, MS4A1 💬
| 25件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
99 | ABBV-006 | - | - | - | - | 1件: 97 97 💬
|
100 | ABBV-066 | - | - | - | - | 2件: 96 96, 97 💬
|
101 | ABBV-0805 | - | - | - | - | 1件: 6 6 💬
|
102 | ABBV-105 | - | - | - | - | 2件: 46 46, 49 💬
|
103 | ABBV-105, A-1519938.0 | - | - | - | - | 1件: 46 46 💬
|
104 | ABBV-119 | - | - | - | - | 1件: 299 299 💬
|
105 | ABBV-154 | - | - | - | - | 2件: 46 46, 96 💬
|
106 | ABBV-2222 | - | - | - | - | 1件: 299 299 💬
|
107 | ABBV-257 | - | - | - | - | 1件: 46 46 💬
|
108 | ABBV-3067 | - | - | - | - | 1件: 299 299 💬
|
109 | ABBV-323 | - | - | - | - | 2件: 53 53, 97 💬
|
110 | ABBV-323 Dose A | - | - | - | - | 1件: 97 97 💬
|
111 | ABBV-323 Dose B | - | - | - | - | 1件: 97 97 💬
|
112 | ABBV-3373 | - | - | - | - | 1件: 46 46 💬
|
113 | ABBV-576 | - | - | - | - | 1件: 299 299 💬
|
114 | ABBV-668 | - | - | - | - | 1件: 97 97 💬
|
115 | ABBV-8E12 | - | - | - | - | 2件: 5 5, 7 💬
|
116 | ABBV-951 | - | - | - | - | 1件: 6 6 💬
|
117 | ABBV-CLS-7262 | - | - | - | - | 1件: 2 2 💬
|
118 | ABC | - | - | - | - | 2件: 256 256, 265 💬
|
119 | ABC/DTG/3TC STR - Tablet | - | - | - | - | 1件: 256 256 💬
|
120 | ABC008 | - | - | - | - | 1件: 15 15 💬
|
121 | Abcertin | - | - | - | - | 1件: 19 19 💬
|
122 | ABELCET | 3件: Amphotericin B Amphotericin B, DL-dimyristoylphosphatidylcholine, DL-dimyristoylphosphatidylglycerol | 1件: Amphotericin B
Amphotericin B
💬
| - | - | 1件: 299 299 💬
|
123 | Abelmoschus manihot | - | - | - | - | 1件: 66 66 💬
|
124 | Abemaciclib | 1件: Abemaciclib Abemaciclib | 1件: Abemaciclib
Abemaciclib
💬
| 2件: CDK4 CDK4, CDK6 💬
| 29件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Breast cancer, Cell cycle, Cellular senescence, Chronic myeloid leukemia, Cushing syndrome, Endocrine resistance, Epstein-Barr virus infection, Glioma, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Measles, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Viral carcinogenesis, p53 signaling pathway 💬 | 1件: 34 34 💬
|
125 | Abetimus | 1件: Abetimus Abetimus | - | - | - | 1件: 49 49 💬
|
126 | ABETIMUS SODIUM | 1件: Abetimus Abetimus | - | - | - | 1件: 49 49 💬
|
127 | Abetimus sodium (LJP 394) | 1件: Abetimus Abetimus | - | - | - | 1件: 49 49 💬
|
128 | AbGn-168H | - | - | - | - | 1件: 97 97 💬
|
129 | ABH001 | 1件: ABH001 ABH001 | - | - | - | 1件: 36 36 💬
|
130 | ABI-M201 | - | - | - | - | 1件: 97 97 💬
|
131 | Abiraterone | 1件: Abiraterone Abiraterone | - | - | - | 2件: 75 75, 81 💬
|
132 | Abiraterone Acetate | 2件: Abiraterone Abiraterone, Acetate | - | - | - | 2件: 75 75, 81 💬
|
133 | Abiraterone acetato | 1件: Abiraterone Abiraterone | - | - | - | 1件: 75 75 💬
|
134 | Abituzumab | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
135 | Abituzumab 1500 mg | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
136 | Abituzumab 500 mg | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
137 | ABO-101 | - | - | - | - | 1件: 19 19 💬
|
138 | ABO-102 | - | - | - | - | 1件: 19 19 💬
|
139 | Abobotulinumtoxin A | - | - | - | - | 1件: 13 13 💬
|
140 | ABP 501 | - | - | - | - | 1件: 46 46 💬
|
141 | ABP 710 | - | - | - | - | 1件: 46 46 💬
|
142 | ABP 710 - Biosimilar to infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
143 | ABP 798 | - | - | - | - | 1件: 46 46 💬
|
144 | ABP 798 - Biosimilar to rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
145 | ABP 798 Biosimilar to Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
146 | ABP 959 | - | - | - | - | 1件: 62 62 💬
|
147 | ABP 959 - biosimilar to eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
148 | ABP 959 - proposed biosimilar to eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
149 | ABPC | 1件: Ampicillin Ampicillin | 1件: Ampicillin
Ampicillin
💬
| - | - | 1件: 84 84 💬
|
150 | ABR-215062 | - | - | - | - | 1件: 13 13 💬
|
151 | ABR-215062 sodium salt | - | - | - | - | 2件: 13 13, 96 💬
|
152 | ABR-215757 | - | - | - | - | 2件: 49 49, 51 💬
|
153 | Abrilumab | 1件: Abrilumab Abrilumab | 1件: Abrilumab
Abrilumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
154 | Abrocitinib | 1件: Abrocitinib Abrocitinib | 1件: Abrocitinib
Abrocitinib
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 84 84 💬
|
155 | Abrocitinib 200 mg | 1件: Abrocitinib Abrocitinib | 1件: Abrocitinib
Abrocitinib
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 84 84 💬
|
156 | ABT 494 | - | - | - | - | 1件: 46 46 💬
|
157 | ABT 494 12mg | - | - | - | - | 2件: 46 46, 96 💬
|
158 | ABT 494 3mg | - | - | - | - | 2件: 46 46, 96 💬
|
159 | ABT Humira | - | - | - | - | 1件: 96 96 💬
|
160 | ABT-122 | - | - | - | - | 1件: 46 46 💬
|
161 | ABT-199 | - | - | - | - | 1件: 49 49 💬
|
162 | ABT-494 | - | - | - | - | 7件: 41 41, 46, 49, 96, 97, 107, 271 💬
|
163 | ABT-494 15mg | - | - | - | - | 1件: 46 46 💬
|
164 | ABT-494 30mg | - | - | - | - | 1件: 46 46 💬
|
165 | ABT-555 | - | - | - | - | 1件: 13 13 💬
|
166 | ABT-874 | - | - | - | - | 1件: 96 96 💬
|
167 | ABT-874/Human monoclonal antibody against IL-12 | - | - | - | - | 1件: 13 13 💬
|
168 | ABT-Humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
169 | ABT-SLV187 | - | - | - | - | 1件: 6 6 💬
|
170 | ABX-1431 | 1件: ABX-1431 ABX-1431 | - | - | - | 1件: 13 13 💬
|
171 | ABX-1431 HCl | 1件: ABX-1431 ABX-1431 | - | - | - | 1件: 13 13 💬
|
172 | ABX464 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
173 | ABX464 100mg | - | - | - | - | 2件: 46 46, 97 💬
|
174 | ABX464 25mg | - | - | - | - | 1件: 97 97 💬
|
175 | ABX464 50mg | - | - | - | - | 2件: 46 46, 97 💬
|
176 | ABY-035 | - | - | - | - | 1件: 271 271 💬
|
177 | AC-203 | - | - | - | - | 1件: 36 36 💬
|
178 | AC-203 1% Topical Ointment | - | - | - | - | 1件: 162 162 💬
|
179 | AC0058TA | - | - | - | - | 1件: 49 49 💬
|
180 | AC430 | - | - | - | - | 1件: 46 46 💬
|
181 | Acalabrutinib | 1件: Acalabrutinib Acalabrutinib | 1件: Acalabrutinib
Acalabrutinib
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 2件: 46 46, 61 💬
|
182 | Acamprosate | 1件: Acamprosate Acamprosate | 1件: Acamprosate
Acamprosate
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 206 💬
|
183 | Acarbose | 1件: Acarbose Acarbose | 1件: Acarbose
Acarbose
💬
| 5件: AMY2A AMY2A, AMY2B, GAA, GANC, MGAM 💬
| 7件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 💬
|
184 | Acazicolcept | - | - | - | - | 1件: 49 49 💬
|
185 | ACC | - | - | - | - | 1件: 299 299 💬
|
186 | ACC600Tabs | - | - | - | - | 1件: 299 299 💬
|
187 | Accelerated 1 hour-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
188 | Accelerated 30 minutes-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
189 | Access program - sildenafil citrate, Viagra, Revatio | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬
| 1件: PDE5A PDE5A 💬
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
190 | Accordion Pill Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
191 | Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
192 | Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
193 | Accordion Pill? Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
194 | Accordion Pill? Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
195 | Accordion Pill¿ Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
196 | Accordion Pill™ Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
197 | Accordion Pill™ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
198 | Accordion Pill™ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
199 | Accupro | - | - | - | - | 1件: 19 19 💬
|
200 | Accuretic | 1件: Quinapril Quinapril | 1件: Quinapril
Quinapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 19 19 💬
|
201 | ACE I, ATA II and Statins | - | - | - | - | 1件: 218 218 💬
|
202 | ACE inhibitor | - | - | - | - | 1件: 66 66 💬
|
203 | ACE inhibitor + statin | - | - | - | - | 1件: 66 66 💬
|
204 | ACE Inhibitor or Angiotensin receptor antagonist | 1件: Angiotensin II Angiotensin II | 2件: Angiotensin II
Angiotensin II
,
Angiotensin II
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
205 | ACE-011 | - | - | - | - | 1件: 86 86 💬
|
206 | ACE-011 / MK - 7962 | - | - | - | - | 1件: 86 86 💬
|
207 | ACE-011 / MK-7962 | - | - | - | - | 1件: 86 86 💬
|
208 | ACE-011/ MK-7962 | - | - | - | - | 1件: 86 86 💬
|
209 | ACE-031 (Extension of cohort 1 from core study, A031-03) | - | - | - | - | 1件: 113 113 💬
|
210 | ACE-031 (Extension of cohort 2 from core study, A031-03) | - | - | - | - | 1件: 113 113 💬
|
211 | ACE-031 (Extension of cohort 3 from core study, A031-03) | - | - | - | - | 1件: 113 113 💬
|
212 | ACE-031 0.5 mg/kg q4wk | - | - | - | - | 1件: 113 113 💬
|
213 | ACE-031 1.0 mg/kg q2wk | - | - | - | - | 1件: 113 113 💬
|
214 | ACE-083 | - | - | - | - | 2件: 10 10, 113 💬
|
215 | ACE-inhibitor | - | - | - | - | 1件: 218 218 💬
|
216 | ACE/ARB | - | - | - | - | 1件: 66 66 💬
|
217 | Acebilustat | 1件: Acebilustat Acebilustat | - | - | - | 1件: 299 299 💬
|
218 | Aceclofenac | 1件: Aceclofenac Aceclofenac | 1件: Aceclofenac
Aceclofenac
💬
| 3件: PTGES PTGES, PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
219 | ACEi | - | - | - | - | 2件: 66 66, 224 💬
|
220 | ACEI/ARB and corticosteroids | - | - | - | - | 1件: 66 66 💬
|
221 | Acellbia | - | - | - | - | 1件: 46 46 💬
|
222 | ACENEURAMIC ACID | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
223 | Aceneuramic Acid Extended-Release | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
224 | Aceneuramic acid extended-release (Ace-ER) | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
225 | Aceneuramic Acid Extended-Release Tablets | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
226 | ACER-002 (celiprolol) 200 mg BID | 1件: Celiprolol Celiprolol | 1件: Celiprolol
Celiprolol
💬
| 1件: ADRB1 ADRB1 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 168 168 💬
|
227 | Acetamide | 1件: Acetamide Acetamide | - | - | - | 2件: 86 86, 154 💬
|
228 | Acetaminophen | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 13件: 11 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
|
229 | Acetaminophen Tablet 650mg | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
230 | Acetaminophen tablets | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
231 | Acetaminophen/paracetamol | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 35 35, 49 💬
|
232 | Acetate | 1件: Acetate Acetate | - | - | - | 41件: 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
|
233 | ACETATO DI AMMONIO | - | - | - | - | 1件: 97 97 💬
|
234 | Acetazolamide | 1件: Acetazolamide Acetazolamide | 1件: Acetazolamide
Acetazolamide
💬
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 6件: 13 13, 90, 115, 155, 225, 230 💬
|
235 | Acetazolamide Sandoz 250 | 1件: Acetazolamide Acetazolamide | 1件: Acetazolamide
Acetazolamide
💬
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬
| 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 225 225 💬
|
236 | Acetic acid | 1件: Acetic acid Acetic acid | 1件: Acetic acid, glacial
Acetic acid, glacial
💬
| - | - | 1件: 97 97 💬
|
237 | Acetohydroxamic Acid | 1件: Acetohydroxamic acid Acetohydroxamic acid | 1件: Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | 1件: 251 251 💬
|
238 | Acetohydroxamic Acid Oral Tablet [Lithostat] | 1件: Acetohydroxamic acid Acetohydroxamic acid | 1件: Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | 1件: 251 251 💬
|
239 | Acetominofene | - | - | - | - | 2件: 11 11, 63 💬
|
240 | Acetominophen | - | - | - | - | 1件: 63 63 💬
|
241 | ACETYL- L- CARNITINE | 1件: Levocarnitine Levocarnitine | 1件: Levocarnitine
Levocarnitine
💬
| - | - | 1件: 265 265 💬
|
242 | Acetyl-L-carnitine | 2件: Acetylcarnitine Acetylcarnitine, Levocarnitine | 1件: Levocarnitine
Levocarnitine
💬
| - | - | 1件: 298 298 💬
|
243 | Acetyl-L-carnitine 1000mg 2X per day for 3 months | 2件: Acetylcarnitine Acetylcarnitine, Levocarnitine | 1件: Levocarnitine
Levocarnitine
💬
| - | - | 1件: 298 298 💬
|
244 | Acetyl-l-leucine | 2件: L-Acetylleucine L-Acetylleucine, Leucine | 1件: Leucine
Leucine
💬
| - | - | 2件: 19 19, 65 💬
|
245 | Acetylcarnitine | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 2件: 2 2, 265 💬
|
246 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 21件: 6 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬
|
247 | Acetylcysteine Effervescent Tablets | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 1件: 85 85 💬
|
248 | ACETYLCYSTEINE SODIUM | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 1件: 299 299 💬
|
249 | ACETYLSALICYLIC ACID | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 51, 210 💬
|
250 | Acetylsalicylic acid at 1st visit, | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
251 | ACH-0144471 | - | - | - | - | 2件: 62 62, 222 💬
|
252 | ACH-0144471 compresse | - | - | - | - | 1件: 222 222 💬
|
253 | ACH-0145228 | - | - | - | - | 1件: 62 62 💬
|
254 | ACH0144471 | - | - | - | - | 1件: 222 222 💬
|
255 | ACH0144471 compresse | - | - | - | - | 1件: 222 222 💬
|
256 | ACHIM | - | - | - | - | 1件: 51 51 💬
|
257 | ACHIM as solute (10^9 intestinal microbes/ml) | - | - | - | - | 1件: 51 51 💬
|
258 | ACHIM capsules | - | - | - | - | 1件: 51 51 💬
|
259 | Aciclin | - | - | - | - | 1件: 28 28 💬
|
260 | Aciclovir | 1件: Acyclovir Acyclovir | 1件: Acyclovir
Acyclovir
💬
| - | - | 3件: 13 13, 28, 60 💬
|
261 | Acid mycophenolic (Myfortic) | 1件: Mycophenolic acid Mycophenolic acid | 1件: Mycophenolic acid
Mycophenolic acid
💬
| 2件: IMPDH1 IMPDH1, IMPDH2 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 222 222 💬
|
262 | Acide folique | 1件: Folic acid Folic acid | 1件: Folic acid
Folic acid
💬
| - | - | 1件: 46 46 💬
|
263 | ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable | - | - | - | - | 1件: 299 299 💬
|
264 | ACIDO ASCORBICO | - | - | - | - | 1件: 10 10 💬
|
265 | ACIDO ASCORBICO DC.IT | - | - | - | - | 1件: 10 10 💬
|
266 | ACIDO DEOSSICOLICO | - | - | - | - | 1件: 94 94 💬
|
267 | Acido fusidico | 1件: Fusidic acid Fusidic acid | 1件: Fusidic acid
Fusidic acid
💬
| - | - | 1件: 272 272 💬
|
268 | ACIDO FUSIDICO/IDROCORTISONE ACETATO | 1件: Fusidic acid Fusidic acid | 1件: Fusidic acid
Fusidic acid
💬
| - | - | 1件: 272 272 💬
|
269 | Acido Micofenolico | 1件: Mycophenolic acid Mycophenolic acid | 1件: Mycophenolic acid
Mycophenolic acid
💬
| 2件: IMPDH1 IMPDH1, IMPDH2 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 49 49 💬
|
270 | Acido Obeticolico | - | - | - | - | 2件: 93 93, 94 💬
|
271 | Acido Sialico - Sialic acid (INN: aceneuramic acid) | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
272 | ACIDO TAUROURSODESOSSICOLICO | - | - | - | - | 1件: 2 2 💬
|
273 | Acido ursodessicolico | - | - | - | - | 1件: 93 93 💬
|
274 | Acidophilus | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 2件: 6 6, 97 💬
|
275 | Acidum ascorbicum | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 1件: 206 206 💬
|
276 | ACIDUM ASCORBICUM D6 | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 1件: 206 206 💬
|
277 | Acipimox | 1件: Acipimox Acipimox | 1件: Acipimox
Acipimox
💬
| - | - | 2件: 78 78, 265 💬
|
278 | Acitretin | 1件: Acitretin Acitretin | 1件: Acitretin
Acitretin
💬
| 5件: RARA RARA, RARB, RXRA, RXRB, RXRG 💬
| 19件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 37 37 💬
|
279 | Aclasta | 1件: Zoledronic acid Zoledronic acid | 2件: Zoledronic acid
Zoledronic acid
,
Zoledronic acid
💬
| 1件: FDPS FDPS 💬
| 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 13 13, 271, 274 💬
|
280 | Aclasta 5 mg Infusionslösung | 1件: Zoledronic acid Zoledronic acid | 2件: Zoledronic acid
Zoledronic acid
,
Zoledronic acid
💬
| 1件: FDPS FDPS 💬
| 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
281 | Aclasta 5mg solution for infusion | - | - | - | - | 1件: 13 13 💬
|
282 | ACM | - | - | - | - | 1件: 49 49 💬
|
283 | ACN00177 | - | - | - | - | 1件: 337 337 💬
|
284 | Acomplia | 1件: Rimonabant Rimonabant | 1件: Rimonabant
Rimonabant
💬
| 1件: CNR1 CNR1 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 💬
|
285 | ACOMPLIA 20 mg film-coated tablets | 1件: Rimonabant Rimonabant | 1件: Rimonabant
Rimonabant
💬
| 1件: CNR1 CNR1 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 193 193 💬
|
286 | Acoramidis | - | - | - | - | 1件: 28 28 💬
|
287 | Acotiamide | 1件: Acotiamide Acotiamide | - | - | - | 1件: 51 51 💬
|
288 | Acoziborole | 1件: Acoziborole Acoziborole | - | - | - | 1件: 65 65 💬
|
289 | Acoziborole (SCYX-7158) | 1件: Acoziborole Acoziborole | - | - | - | 1件: 65 65 💬
|
290 | ACP-001 | - | - | - | - | 1件: 78 78 💬
|
291 | ACP-001 (TransCon hGH) | - | - | - | - | 1件: 78 78 💬
|
292 | ACP-011 | - | - | - | - | 1件: 78 78 💬
|
293 | ACP-103 | - | - | - | - | 1件: 6 6 💬
|
294 | ACR16 | - | - | - | - | 1件: 8 8 💬
|
295 | ACR16 10 mg | - | - | - | - | 1件: 8 8 💬
|
296 | ACR16 22.5 mg | - | - | - | - | 1件: 8 8 💬
|
297 | ACR16 45 mg | - | - | - | - | 1件: 8 8 💬
|
298 | ACR16 hydrochloride, ASP2314 hydrochloride, FR310826 | - | - | - | - | 1件: 8 8 💬
|
299 | ACR325 | 1件: ACR325 ACR325 | - | - | - | 1件: 6 6 💬
|
300 | ACT | - | - | - | - | 1件: 13 13 💬
|
301 | ACT - 064992 | - | - | - | - | 1件: 86 86 💬
|
302 | ACT-050089 | - | - | - | - | 1件: 86 86 💬
|
303 | ACT-050089 (Ro 61-0612) | - | - | - | - | 1件: 86 86 💬
|
304 | ACT-064992 | - | - | - | - | 5件: 51 51, 85, 86, 88, 210 💬
|
305 | ACT-064992 (macitentan) | 1件: Macitentan Macitentan | 1件: Macitentan
Macitentan
💬
| 2件: EDNRA EDNRA, EDNRB 💬
| 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 💬
|
306 | ACT-064992 / JNJ-67896062 | - | - | - | - | 1件: 86 86 💬
|
307 | ACT-064992/ JNJ-67896062 | - | - | - | - | 1件: 86 86 💬
|
308 | ACT-064992D | - | - | - | - | 1件: 86 86 💬
|
309 | ACT-1 | - | - | - | - | 1件: 13 13 💬
|
310 | ACT-128800 | - | - | - | - | 1件: 13 13 💬
|
311 | ACT-128800 Dose 1 | - | - | - | - | 1件: 13 13 💬
|
312 | ACT-128800 Dose 2 | - | - | - | - | 1件: 13 13 💬
|
313 | ACT-128800 Dose 3 | - | - | - | - | 1件: 13 13 💬
|
314 | ACT-178418 | - | - | - | - | 1件: 86 86 💬
|
315 | ACT-293987 | - | - | - | - | 3件: 51 51, 86, 88 💬
|
316 | ACT-293987 (NS-304) | - | - | - | - | 1件: 86 86 💬
|
317 | ACT-293987 / JNJ-67896049 | - | - | - | - | 1件: 84 84 💬
|
318 | ACT-334441 | - | - | - | - | 1件: 49 49 💬
|
319 | ACT-385781A | - | - | - | - | 1件: 86 86 💬
|
320 | ACT-385781A (Actelion Epoprostenol) | 1件: Epoprostenol Epoprostenol | 1件: Epoprostenol
Epoprostenol
💬
| 1件: PTGIR PTGIR 💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 💬
|
321 | ACT-434964 | - | - | - | - | 1件: 19 19 💬
|
322 | Act-HiB | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 4件: 14 14, 61, 62, 222 💬
|
323 | ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 2件: 61 61, 62 💬
|
324 | Actemra | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 💬
|
325 | Actemra(EU-licensed) | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
326 | Actemra, MRA | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 107 107 💬
|
327 | Acteoside | 1件: Acteoside Acteoside | - | - | - | 1件: 66 66 💬
|
328 | ACTH | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 4件: 13 13, 66, 145, 222 💬
|
329 | ACTH (Acthar) Gel | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 66 66 💬
|
330 | Acthar | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 9件: 2 2, 13, 14, 46, 49, 50, 66, 84, 222 💬
|
331 | Acthar 80 unit injection | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 66 66 💬
|
332 | Acthar Gel | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 13 13, 46, 49, 50, 84, 222 💬
|
333 | ACTHAR Gel (ACTH) | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
334 | ACTHAR Gel (adrenocorticotropic hormone) | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 💬
|
335 | ACTHAR Gel 40 units twice weekly | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 💬
|
336 | ACTHAR Gel 80 units twice weekly. | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 💬
|
337 | Acthar high dose (80 U) | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 49 49 💬
|
338 | Acthar Injectable Product | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 46 46 💬
|
339 | Acthar low dose (40 U) | 1件: Corticotropin Corticotropin | 1件: Corticotropin
Corticotropin
💬
| 1件: MC2R MC2R 💬
| 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 49 49 💬
|
340 | ActHIB | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 2件: 62 62, 66 💬
|
341 | ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML | 1件: Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | 2件: 62 62, 66 💬
|
342 | Acthrel | 1件: Corticorelin ovine triflutate Corticorelin ovine triflutate | 1件: Corticorelin ovine triflutate
Corticorelin ovine triflutate
💬
| 2件: CRHR1 CRHR1, CRHR2 💬
| 4件: Cushing syndrome Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 💬
|
343 | ACTIMMUNE | 1件: Interferon gamma-1b Interferon gamma-1b | 1件: Interferon gamma-1b
Interferon gamma-1b
💬
| 2件: IFNGR1 IFNGR1, IFNGR2 💬
| 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 1件: 326 326 💬
|
344 | Actimmune Registry | 1件: Interferon gamma-1b Interferon gamma-1b | 1件: Interferon gamma-1b
Interferon gamma-1b
💬
| 2件: IFNGR1 IFNGR1, IFNGR2 💬
| 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 1件: 326 326 💬
|
345 | Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily. | - | - | - | - | 1件: 276 276 💬
|
346 | Active comparator | - | - | - | - | 2件: 6 6, 46 💬
|
347 | Active Comparator receiving Extavia® | 1件: Interferon beta-1b Interferon beta-1b | 1件: Interferon beta-1b
Interferon beta-1b
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
348 | Active Control | - | - | - | - | 1件: 13 13 💬
|
349 | Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. | - | - | - | - | 1件: 6 6 💬
|
350 | Active drug: pimavanserin 17mg (2 strength tablets) | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 💬
|
351 | Active Investigational Treatment ENT-01 | - | - | - | - | 1件: 6 6 💬
|
352 | Active topical NS2 1% dermatologic cream | - | - | - | - | 1件: 160 160 💬
|
353 | Active Treatment Group 7% Hypertonic Saline | - | - | - | - | 1件: 299 299 💬
|
354 | ActiveMatrix | - | - | - | - | 1件: 70 70 💬
|
355 | Actonel 5mg Film Coated Tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬
| 1件: FDPS FDPS 💬
| 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
356 | Actonel Once a Week 35 mg film-coated tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬
| 1件: FDPS FDPS 💬
| 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
357 | Actonel Once a week 5mg film coated tablets | 1件: Risedronic acid Risedronic acid | 1件: Risedronic acid
Risedronic acid
💬 |